The state of play in the field of CRISPR diagnostics has been changing rapidly. Here, Bryan DeChairo, CEO of Sherlock Biosciences, discusses the...

As the COVID-19 pandemic continues to evolve with fluctuating restrictions worldwide, mass vaccine rollouts and the emergence of new variants, it's...

Extremely precise biosensors embedded into clothing could inform doctors or scientists that they've been exposed to a dangerous germ. The sensors can...

This week’s update looks at a CRISPR-Cas12a-based detection method, developed in China as a confirmatory tool to aid SARS-CoV-2 diagnosis.

Andre Watson, the founder of the gene delivery platform company Ligandal, quickly pivoted his company to develop a therapeutic for COVID-19. But he...

This year CRISPR broke new ground in medicine. We saw the first CRISPR gene editing directly in the body, CRISPR took huge wins in clinical trials and...

The new electric field-driven 'lab-on-a-chip' use CRISPR-Cas12 to rapidly detect the SARS-CoV-2 in nasal-swap samples. The device is portable and can...

We have added three clinical trials to our comprehensive database of the current CRISPR-based trials for gene-editing therapies and diagnostics. This...